AAAAAA

   
Results: 1-5 |
Results: 5

Authors: TJULANDIN SA STENINA MB SIDOROVA NJ DELGADO FG SOKOLOV AV MOLCHANOV GV LJUBIMOVA NV GARIN AM
Citation: Sa. Tjulandin et al., PHASE I II TRIAL OF CARBOPLATIN DOSE-ESCALATION IN COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, BLEOMYCIN AND GM-CSF SUPPORT FOR POOR-PROGNOSISNONSEMINOMATOUS GERM-CELL TUMORS PATIENTS/, Neoplasma, 43(5), 1996, pp. 347-352

Authors: KARPOV SA TJULANDIN SA MOLCHANOV GV GARIN AM
Citation: Sa. Karpov et al., THE ROLE OF A CYTOREDUCTIVE SURGERY IN NONSEMINOMATOUS GERM-CELL TUMOR PATIENTS WITH SMALL RETROPERITONEAL MASS AFTER INDUCTION CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 914-914

Authors: TJULANDIN SA GARIN AM
Citation: Sa. Tjulandin et Am. Garin, SECONDARY LEUKEMIA CAUSED BY ETOPOSIDE CONTAINING CHEMOTHERAPY IN GERM-CELL CANCER-PATIENTS, European journal of cancer, 31A, 1995, pp. 920-920

Authors: DELGADO FG TJULANDIN SA GARIN AM
Citation: Fg. Delgado et al., LONG-TERM RESULTS OF TREATMENT IN PATIENTS WITH EXTRAGONADAL GERM-CELL TUMORS, European journal of cancer, 29A(7), 1993, pp. 1002-1005

Authors: TJULANDIN SA GARIN AM MESCHERYAKOV AA PEREVODCHIKOVA NI GORBUNOVA VA SOKOLOV AV LJUBIMOVA NV MIRONOVA GT MOLCHANOV GV OZOLS RF HAMILTON JM
Citation: Sa. Tjulandin et al., CISPLATIN-ETOPOSIDE AND CARBOPLATIN-ETOPOSIDE INDUCTION CHEMOTHERAPY FOR GOOD-RISK PATIENTS WITH GERM-CELL TUMORS, Annals of oncology, 4(8), 1993, pp. 663-667
Risultati: 1-5 |